What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel

Bratan, 2013, Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study, Eur Radiol, 23, 2019, 10.1007/s00330-013-2795-0

Kim, 2014, Low-risk prostate cancer: the accuracy of multiparametric MR imaging for detection, Radiology, 271, 435, 10.1148/radiol.13130801

Turkbey, 2010, Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation, Radiology, 255, 89, 10.1148/radiol.09090475

Valerio, 2015, Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review, Eur Urol, 68, 8, 10.1016/j.eururo.2014.10.026

Schoots, 2015, Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis, Eur Urol, 68, 438, 10.1016/j.eururo.2014.11.037

Wegelin, 2017, Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique?, Eur Urol, 71, 517, 10.1016/j.eururo.2016.07.041

Schoots, 2016, Omission of systematic transrectal ultrasound guided biopsy from the MRI targeted approach in men with previous negative prostate biopsy might still be premature, Ann Transl Med, 4, 205, 10.21037/atm.2016.03.53

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135

Whiting, 2011, QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, 155, 529, 10.7326/0003-4819-155-8-201110180-00009

Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y

Abd-Alazeez, 2014, The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—can it rule out clinically significant prostate cancer?, Urol Oncol, 32, 45, 10.1016/j.urolonc.2013.06.007

Abd-Alazeez, 2014, Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard, Prostate Cancer Prostatic Dis, 17, 40, 10.1038/pcan.2013.43

Belas, 2012, IRM mutiparamétrique de la prostate avant biopsies: la fin des biopsies systématisées?, Prog Urol, 22, 583, 10.1016/j.purol.2012.03.007

Busetto, 2013, Prostate cancer gene 3 and multiparametric magnetic resonance can reduce unnecessary biopsies: decision curve analysis to evaluate predictive models, Urology, 82, 1355, 10.1016/j.urology.2013.06.078

Cheikh, 2009, Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy, Eur Radiol, 19, 770, 10.1007/s00330-008-1190-8

Choi, 2011, The clinical value of performing an MRI before prostate biopsy, Korean J Urol, 52, 572, 10.4111/kju.2011.52.8.572

Cirillo, 2008, Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours, Clin Radiol, 63, 871, 10.1016/j.crad.2007.10.020

Ferda, 2013, A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy, Anticancer Res, 33, 2791

Ganie, 2013, Endorectal coil MRI and MR-spectroscopic imaging in patients with elevated serum prostate specific antigen with negative TRUS transrectal ultrasound guided biopsy, Urol Ann, 5, 172, 10.4103/0974-7796.115741

Grenabo Bergdahl, 2016, Role of magnetic resonance imaging in prostate cancer screening: a pilot study within the Göteborg randomised screening trial, Eur Urol, 70, 566, 10.1016/j.eururo.2015.12.006

Haffner, 2011, Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection, BJU Int, 108, E171, 10.1111/j.1464-410X.2011.10112.x

Hara, 2005, Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer, Prostate, 62, 140, 10.1002/pros.20124

Hauth, 2015, of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy, Br J Radiol, 88, 20150422, 10.1259/bjr.20150422

Ibrahiem, 2012, DWI-MRI: single, informative, and noninvasive technique for prostate cancer diagnosis, Sci World J, 2012, 973450, 10.1100/2012/973450

Itatani, 2014, Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies, Eur J Radiol, 83, 1740, 10.1016/j.ejrad.2014.06.026

Iwazawa, 2011, Prostate cancer detection with magnetic resonance imaging: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?, Diagn Interv Radiol, 17, 243

Javali, 2014, Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10ng/mL and normal digital rectal examination: MRSI-directed TRUS biopsy in prostate cancer, Int J Urol, 21, 257, 10.1111/iju.12258

Junker, 2013, Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer, BioMed Res Int, 2013, 252939, 10.1155/2013/252939

Kitajima, 2010, Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging, J Magn Reson Imaging, 31, 625, 10.1002/jmri.22075

Kumar, 2009, Potential of 1H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy, J Magn Reson Imaging, 30, 842, 10.1002/jmri.21898

Kumar, 2007, Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional1H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10ng/ml, NMR Biomed, 20, 11, 10.1002/nbm.1083

Kuru, 2013, Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer, J Urol, 190, 1380, 10.1016/j.juro.2013.04.043

Labanaris, 2010, Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate, Prostate Cancer Prostatic Dis, 13, 65, 10.1038/pcan.2009.41

Lamb, 2015, Is prebiopsy MRI good enough to avoid prostate biopsy?. A cohort study over a 1-year period, Clin Genitourin Cancer, 13, 512, 10.1016/j.clgc.2015.06.007

Matsuoka, 2014, Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy, Eur Urol, 65, 186, 10.1016/j.eururo.2012.10.010

Numao, 2013, Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer, J Urol, 190, 502, 10.1016/j.juro.2013.02.3197

Panebianco, 2015, Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study, Urol Oncol, 33, 10.1016/j.urolonc.2014.09.013

Panebianco, 2010, Role of magnetic resonance spectroscopic imaging ([1H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA), La Radiol Med, 115, 1314, 10.1007/s11547-010-0575-3

Pepe, 2015, Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA <10ng/mL?, Clin Genitourin Cancer, 13, e27, 10.1016/j.clgc.2014.06.013

Petrillo, 2014, Multiparametric MRI for prostate cancer detection: performance in patients with prostate-specific antigen values between 2.5 and 10ng/mL, J Magn Reson Imaging, 39, 1206, 10.1002/jmri.24269

Pokorny, 2014, Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound–guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies, Eur Urol, 66, 22, 10.1016/j.eururo.2014.03.002

Porpiglia, 2014, The roles of multiparametric magnetic resonance imaging, PCA3 and Prostate Health Index—which is the best predictor of prostate cancer after a negative biopsy?, J Urol, 192, 60, 10.1016/j.juro.2014.01.030

Portalez, 2012, Validation of the European Society of Urogenital Radiology Scoring System for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients, Eur Urol, 62, 986, 10.1016/j.eururo.2012.06.044

Radtke, 2015, Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance, J Urol, 193, 87, 10.1016/j.juro.2014.07.098

Rais-Bahrami, 2013, Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer, J Urol, 190, 1721, 10.1016/j.juro.2013.05.052

Rouse, 2011, Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study, Urol Int, 87, 49, 10.1159/000325880

Schmuecking, 2009, Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?, Int J Radiat Biol, 85, 814, 10.1080/09553000903090027

Sciarra, 2012, Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy, BJU Int, 110, 1661, 10.1111/j.1464-410X.2012.11146.x

Squillaci, 2005, MR spectroscopy of prostate cancer. Initial clinical experience, J Exp Clin Cancer Research, 24, 523

Testa, 2010, Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy, NMR Biomed, 23, 1017, 10.1002/nbm.1522

Thompson, 2014, Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study, J Urol, 192, 67, 10.1016/j.juro.2014.01.014

Vinet, 2013, Le score PCA3 et l’IRM prostatique permettent-ils de sélectionner les patients candidats a une première série de biopsies prostatiques?, Prog Urol, 23, 121, 10.1016/j.purol.2012.09.005

Wang, 2015, Evaluation of multiparametric magnetic resonance imaging in detection and prediction of prostate cancer, PLoS One, 10, e0130207, 10.1371/journal.pone.0130207

Watanabe, 2012, Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study, J Magn Reson Imaging, 35, 1414, 10.1002/jmri.23587

Barentsz, 2016, Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use, Eur Urol., 69, 41, 10.1016/j.eururo.2015.08.038

Renard-Penna, 2015, Prostate Imaging Reporting and Data System and Likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy, Radiology, 275, 458, 10.1148/radiol.14140184

Vache, 2014, Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy, Radiology, 272, 446, 10.1148/radiol.14131584

Eggener, 2015, Gleason 6 prostate cancer: translating biology into population health, J Urol, 194, 626, 10.1016/j.juro.2015.01.126

Van der Kwast, 2012, Re: should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings, Eur Urol, 61, 220, 10.1016/j.eururo.2011.10.015

Singh, 2004, Predictors of prostate cancer after initial negative systematic 12 core biopsy, J Urol, 171, 1850, 10.1097/01.ju.0000119667.86071.e7

Mian, 2002, Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy, Urology, 60, 836, 10.1016/S0090-4295(02)01950-7

Ahmed, 2017, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1

Hansen, 2017, The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting, BJU Int, 119, 724, 10.1111/bju.13619

Washino, 2017, Combination of PI-RADS score and PSA density predicts biopsy outcome in biopsy naive patients, BJU Int, 119, 225, 10.1111/bju.13465

Louie, 2015, Do prostate cancer risk models improve the predictive accuracy of PSA screening?. A meta-analysis, Ann Oncol, 26, 848, 10.1093/annonc/mdu525

van Vugt, 2012, Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort, Eur J Cancer, 48, 1809, 10.1016/j.ejca.2012.02.002

Mozer, 2015, First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer, BJU Int, 115, 50, 10.1111/bju.12690

Liddell, 2015, mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer—a retrospective review of 92 biopsied PIRADS 3 lesions, Curr Urol, 8, 96, 10.1159/000365697

Weinreb, 2016, PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2, Eur Urol, 69, 16, 10.1016/j.eururo.2015.08.052

Mertan, 2016, Prospective evaluation of the Prostate Imaging Reporting and Data System Version 2 for prostate cancer detection, J Urol, 196, 690, 10.1016/j.juro.2016.04.057

Rosenkrantz, 2016, Prostate Imaging Reporting and Data System (PI-RADS), Version 2: a critical look, AJR Am J Roentgenol, 206, 1179, 10.2214/AJR.15.15765

Hoang Dinh, 2016, Quantitative analysis of prostate multiparametric MR images for detection of aggressive prostate cancer in the peripheral zone: a multiple imager study, Radiology, 280, 117, 10.1148/radiol.2016151406

Rosenkrantz, 2016, Interobserver reproducibility of the PI-RADS Version 2 Lexicon: a multicenter study of six experienced prostate radiologists, Radiology, 280, 793, 10.1148/radiol.2016152542

Muller, 2015, Prostate cancer: interobserver agreement and accuracy with the revised Prostate Imaging Reporting and Data System at multiparametric MR imaging, Radiology, 277, 741, 10.1148/radiol.2015142818